Open original FDA record ↗Recall record
- FDA identifier
- Z-2038-2023
- Company in FDA record
- Remel, Inc
- FDA classification date
- Jun 29, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The test medium may not perform as intended.
Source facts
- Action
- The firm issued recall letters dated 5/31/2023 via mail on 5/31/2023 that were flagged as URGENT: Deliver to Micro Lab. The letter provides the reason for the field action, risk to health, the product and distribution information, and actions to be taken by the customer. The actions included the consignee review reported results by an appropriate technical expert. The letter should be passed onto all who need to be aware within the consignee's organization or to any organization where the affected products have been transferred. An Acknowledgement Form was enclosed for return to the firm via email. The form is for the consignee to acknowledge receipt of the recall notice and that it is understood, and the information and required actions have been brought to the attention of all relevant users and executed. The deadline for returning the form is 6/30/2023.
- Initiated
- 2023-05-31
- Root cause
- Under Investigation by firm
- Distribution
- Distribution was made nationwide, including Puerto Rico. There was no foreign or military distribution.
- Recall number
- Z-2038-2023
- Recall status
- Open, Classified
- CDRH record ID
- 200916
- FDA classified
- 2023-06-29
- Recall event number
- 92444